Sean Lavin
Stock Analyst at BTIG
(3.06)
# 1,113
Out of 5,182 analysts
37
Total ratings
80%
Success rate
33.17%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $23.57 | - | 4 | Nov 5, 2024 | |
| PODD Insulet | Upgrades: Buy | $320 | $182.87 | +74.99% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $81.90 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $28.46 | +68.66% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $178.51 | - | 4 | Apr 16, 2019 | |
| HSDT Solana Company | Downgrades: Neutral | n/a | $2.08 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Holdings | Upgrades: Buy | $80 | $125.41 | -36.21% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $9.02 | - | 4 | Apr 16, 2018 | |
| ABT Abbott Laboratories | Downgrades: Neutral | n/a | $93.86 | - | 1 | Jan 22, 2018 | |
| BSX Boston Scientific | Upgrades: Buy | n/a | $58.45 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $59.32 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $82.28 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $23.57
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $182.87
Upside: +74.99%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $81.90
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $28.46
Upside: +68.66%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $178.51
Upside: -
Solana Company
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $2.08
Upside: -
iRhythm Holdings
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $125.41
Upside: -36.21%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $9.02
Upside: -
Abbott Laboratories
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $93.86
Upside: -
Boston Scientific
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $58.45
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $59.32
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $82.28
Upside: -